Latest stories on ZURA
Zura Bio price target lowered to $10 from $18 at Clear Street
The Fly34 · bearishanalyst
Zura Bio price target lowered to $8 from $20 at Guggenheim
The Fly28 · bearishanalyst
Zura Bio price target lowered to $5 from $16 at Oppenheimer
The Fly28 · bearishanalyst
ZURA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zura Bio Limited
PR Newswire34 · bearishgeneral
Guggenheim cuts Zura Bio stock price target to $8 on trial failure
Investing.com Analyst Ratings24 · bearishanalyst
Zura Bio Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Zura Bio Limited (ZURA)
PR Newswire34 · bearishgeneral
Zura Bio Price Target Lowered To 5 From 11 At Leerink
The Fly34 · bearishanalyst
Why Is Zura Bio Stock (ZURA) Down 70% Today?
TipRanks12 · bearishearnings
ZURA Maintained by Wedbush -- Price Target Lowered to $10.00
GuruFocus42 · neutralanalyst
Zura Bio price target lowered to $10 from $22 at Wedbush
The Fly34 · bearishanalyst
Why is Zura Bio stock collapsing today?
Investing.com Markets22 · bearishgeneral
Zura Bio Discontinues Hidradenitis Suppurativa Development After Trial Miss
TipRanks22 · bearishproduct/pr
Zura Bio Announces Phase 2 Tibushield Study Did Not Meet Primary Endpoint
The Fly22 · bearishearnings
Zura Bio Ltd (ZURA) files 8-K
SEC 8-K50 · neutralgeneral
Zura Bio Provides Clinical Update on Phase 2 TibuSHIELD Study of Tibulizumab (ZB-106) in Hidradenitis Suppurativa
StockTitan55 · neutralproduct/pr
Guggenheim reiterates Zura Bio stock rating on HS market potential
Investing.com Analyst Ratings53 · neutralanalyst
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Zura Bio files $700M mixed securities shelf
The Fly48 · neutralgeneral
Zura Bio shares jump on Wedbush buy call ahead of trial data
Investing.com Markets64 · neutralanalyst
Zura Bio GAAP EPS of -$0.20 in-line
Seeking Alpha52 · neutralearnings
Wedbush would be ‘aggressive buyer’ of Zura Bio ahead of key Q4 catalyst
The Fly64 · neutralanalyst
Zura Bio Ltd Reports Q3 2026 Loss of $25.8 Million, EPS of -$0.20, Outperforming Analyst Estimates
GuruFocus63 · neutralearnings
Zura Bio sees cash runway through at least the end of 2028
The Fly58 · neutralgeneral
Zura Bio reports Q3 EPS (20c), consensus (21c)
The Fly52 · neutralearnings
Zura Bio Ltd (ZURA) files 8-K
SEC 8-K50 · neutralgeneral